Balance Sheet
Accounts PayablesAccumulated DepreciationAccumulated ExpensesAssetsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesLiabilities and Shareholders EquityLong-Term InvestmentsNon-Current AssetsNon-Current Deffered RevenueOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - AccuredRetained EarningsShareholder's EquityTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Metagenomi (MGX) Other Non-Current Liabilities (2023 - 2025)

Metagenomi (MGX) has disclosed Other Non-Current Liabilities for 3 consecutive years, with $2.0 million as the latest value for Q4 2025.

  • Quarterly Other Non-Current Liabilities fell 2.84% to $2.0 million in Q4 2025 from the year-ago period, while the trailing twelve-month figure was $2.0 million through Dec 2025, down 2.84% year-over-year, with the annual reading at $2.0 million for FY2025, 2.84% down from the prior year.
  • Other Non-Current Liabilities for Q4 2025 was $2.0 million at Metagenomi, up from $1.9 million in the prior quarter.
  • The five-year high for Other Non-Current Liabilities was $5.1 million in Q4 2023, with the low at $1.9 million in Q3 2025.
  • Average Other Non-Current Liabilities over 3 years is $3.0 million, with a median of $2.2 million recorded in 2025.
  • The sharpest move saw Other Non-Current Liabilities tumbled 60.43% in 2024, then decreased 2.84% in 2025.
  • Over 3 years, Other Non-Current Liabilities stood at $5.1 million in 2023, then crashed by 60.43% to $2.0 million in 2024, then dropped by 2.84% to $2.0 million in 2025.
  • According to Business Quant data, Other Non-Current Liabilities over the past three periods came in at $2.0 million, $1.9 million, and $2.2 million for Q4 2025, Q3 2025, and Q2 2025 respectively.